Pediatric Brain Tumor Clinical Trials
2 recruiting trials for Pediatric Brain Tumor. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Pediatric Brain Tumor clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by University of Wisconsin, Madison (1), Children's Hospital Medical Center, Cincinnati (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is pNANO Assessment (diagnostic_test, 1 trial), followed by Survivor's Journey+.
Track Pediatric Brain Tumor trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Evaluation of the Neurologic Assessment in Pediatric Neuro-Oncology (pNANO)
This study aims to investigate a neurologic exam scale to provide an objective and more standard way to assess tumor response in pediatric patients with brain and spinal cord...
Survivors Journey+
The main goal of this pilot randomized controlled trial is to learn if an online program called "Survivors Journey" (SJ+) can help teens and young adults, ages 15-25, who are...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Pediatric Brain Tumor, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Pediatric Brain Tumor, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Pediatric Brain Tumor, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.